Leaping to greatness
CUHK charts institutional roadmap for 2026–2030

CUHK has launched its Strategic Plan for 2026–2030, themed ‘Leaping to Greatness’, which presents a roadmap for its next five years. Through its TIGER’s Leaps, spanning Talent attraction and development, Institutional development, Global and alumni engagement, Education and student experience, and Research and innovation, the University is taking decisive leaps forward to translate academic excellence into real-world impact to contribute to society locally, nationally and globally.

CUHK hosts APRU Annual Presidents’ Meeting 2026

CUHK hosted the APRU Annual Presidents’ Meeting and the Senior International Leaders’ Meeting 2026, marking a landmark week for global academic dialogue and exchanges in Hong Kong. About 150 presidents, senior international leaders, and delegates from across the APRU network gathered for a shared commitment to addressing the challenges and opportunities facing higher education in the Asia Pacific and beyond.

Next-generation chip unblocks AI’s data traffic jams

Engineers at CUHK have built a groundbreaking silicon chip that could remove a major bottleneck slowing down the growth of modern AI systems. The chip’s breakthrough innovation lies in its ability to process fibre-optic data signals using light instead of converting them into electrical signals first, supporting ultra-low-latency and greener AI supercomputing.

CUHK School of Architecture has unveiled the Amani Kibera Book House in Kenya, transforming an ageing, half-abandoned structure into a dynamic, multi-functional library and community centre that provides a safe learning environment and public space for up to 400 vulnerable children, teenagers and women daily, significantly improving their living conditions.

Unlocking the key to immunotherapy resistance of liver cancer

Immunotherapy is now a first-line treatment for advanced liver cancer, but many patients eventually develop resistance. CU Medicine has discovered how a type of immune cell can inadvertently help liver cancer cells evade treatment, paving the way for a new combination therapy for patients who do not respond to existing immunotherapies.